Healthy Clinical Trial
— CryotherapyOfficial title:
The Effect of Cryotherapy on Recovery and Performance: A Randomized Controlled Double Blind Trial
| NCT number | NCT02506283 |
| Other study ID # | KEK-ZH-Nr.2015-0113 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 2015 |
| Est. completion date | May 2019 |
| Verified date | October 2017 |
| Source | University of Applied Sciences and Arts of Southern Switzerland |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study investigates the effects of cooling on the recovery and performance characteristic
in young healthy subjects. The study is divided in two projects:
Project A: investigates the effects of 20 min. post-exercise cooling on vertical jump
performance and delayed onset muscle soreness and rated perceived exertion.
Project B: investigates the effects of 20 min. pre-exercise cooling on maximal voluntary
contraction of the right M. quadriceps femoris and delayed onset muscle soreness and rated
perceived exertion.
| Status | Completed |
| Enrollment | 40 |
| Est. completion date | May 2019 |
| Est. primary completion date | November 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 30 Years |
| Eligibility |
Inclusion Criteria: - only healthy young subjects 18-30 years - no musculoskeletal surgery in trunk and lower extremities - injury history in trunk and lower extremity for more than one year - subjects taking anticonceptive medication are allowed to participate Exclusion Criteria: - actual injuries or injuries for less than one year in trunk and /or lower extremities - injury history in trunk and lower extremity for more than one year with complaints - anxiety of cooling - subjects on medication - pace maker - cardiovascular disease - pregnancy - skeletal problems - appendectomy for less than two years - Morbus Raynaud syndrome |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | SUPSI | Landquart | GR |
| Lead Sponsor | Collaborator |
|---|---|
| University of Applied Sciences and Arts of Southern Switzerland | THIM - die internationale Hochschule für Physiotherapie, Universiteit Antwerpen, Vrije Universiteit Brussel |
Switzerland,
Ascensão A, Leite M, Rebelo AN, Magalhäes S, Magalhäes J. Effects of cold water immersion on the recovery of physical performance and muscle damage following a one-off soccer match. J Sports Sci. 2011 Feb;29(3):217-25. doi: 10.1080/02640414.2010.526132. — View Citation
Banfi G, Lombardi G, Colombini A, Melegati G. Whole-body cryotherapy in athletes. Sports Med. 2010 Jun 1;40(6):509-17. doi: 10.2165/11531940-000000000-00000. Review. — View Citation
Barnett A. Using recovery modalities between training sessions in elite athletes: does it help? Sports Med. 2006;36(9):781-96. Review. — View Citation
Bleakley C, McDonough S, Gardner E, Baxter GD, Hopkins JT, Davison GW. Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008262. doi: 10.1002/14651858.CD008262.pub2. — View Citation
Pointon M, Duffield R, Cannon J, Marino FE. Cold application for neuromuscular recovery following intense lower-body exercise. Eur J Appl Physiol. 2011 Dec;111(12):2977-86. doi: 10.1007/s00421-011-1924-1. Epub 2011 Mar 29. — View Citation
Ross ML, Garvican LA, Jeacocke NA, Laursen PB, Abbiss CR, Martin DT, Burke LM. Novel precooling strategy enhances time trial cycling in the heat. Med Sci Sports Exerc. 2011 Jan;43(1):123-33. doi: 10.1249/MSS.0b013e3181e93210. — View Citation
Wegmann M, Faude O, Poppendieck W, Hecksteden A, Fröhlich M, Meyer T. Pre-cooling and sports performance: a meta-analytical review. Sports Med. 2012 Jul 1;42(7):545-64. doi: 10.2165/11630550-000000000-00000. Review. — View Citation
White GE, Wells GD. Cold-water immersion and other forms of cryotherapy: physiological changes potentially affecting recovery from high-intensity exercise. Extrem Physiol Med. 2013 Sep 1;2(1):26. doi: 10.1186/2046-7648-2-26. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The effect of a 20 minute cryotherapy application on vertical jump performance 24 hours post cold application | n= 20 subjects for objective recovery. objective recovery: vertical jump performance (best of three in cm. on just jump plate) 24 hours post cold application is evaluated | 0-24hours post cold application | |
| Primary | The effect of a 20 minute cryotherapy application on vertical jump performance 48 hours post cold application | n= 20 subjects for objective recovery. objective recovery: vertical jump performance (best of three in cm. on just jump plate) 48 hours post cold application is evaluated | 24-48 hours post cold application | |
| Primary | The effect of a 20 minute cryotherapy application on vertical jump performance 72 hours post cold application | n= 20 subjects for objective recovery. objective recovery: vertical jump performance (best of three in cm. on just jump plate) 72 hours post cold application is evaluated | 48-72 hours post cold application | |
| Primary | The effect of a 20 minute cryotherapy application on maximum voluntary contraction 24 hours post cold application | n= 20 subjects for objective performance objective performance: maximum voluntary contraction (best of three in Kg) on ergometer chair (Cor1Bioelectronica) and surface EMG (OT Bioellectronica) 24 hours post cold application is evaluated | 0-24 hours post cold application | |
| Primary | The effect of a 20 minute cryotherapy application on maximum voluntary contraction 48 hours post cold application | n= 20 subjects for objective performance objective performance: maximum voluntary contraction (best of three in Kg) on ergometer chair (Cor1Bioelectronica) and surface EMG (OT Bioellectronica) 48 hours post cold application is evaluated | 24-48 hours post cold application | |
| Primary | The effect of a 20 minute cryotherapy application on maximum voluntary 72 hours post cold application | n= 20 subjects for objective performance objective performance: maximum voluntary contraction (best of three in Kg) on ergometer chair (Cor1Bioelectronica) and surface EMG (OT Bioellectronica) 72 hours post cold application is evaluated | 48-72 hours post cold application | |
| Secondary | The effect of a 20 minute cryotherapy application on delayed onset muscle soreness 24 hours post cold application | n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 24 hours post cold application is evaluated | 0-24 hours post cold application | |
| Secondary | The effect of a 20 minute cryotherapy application on delayed onset muscle soreness 48 hours post cold application | n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 48 hours post cold application is evaluated | 24-48 hours post cold application | |
| Secondary | The effect of a 20 minute cryotherapy application on delayed onset muscle 72 hours post cold application | n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 72 hours post cold application is evaluated | 48-72 hours post cold application | |
| Secondary | The effect of a 20 minute cryotherapy application on rated perceived exertion 24 hours post cold application | n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 24 hours post cold application is evaluated | 0-24 hours post cold application | |
| Secondary | The effect of a 20 minute cryotherapy application on rated perceived exertion 48 hours post cold application | n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 48 hours post cold application is evaluated | 24-48 hours post cold application | |
| Secondary | The effect of a 20 minute cryotherapy application on rated perceived exertion 72 hours post cold application | n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 72 hours post cold application is evaluated | 48-72 hours post cold application |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |